There is no single best pain medication for multiple sclerosis because MS causes several distinct types of pain, each requiring a different treatment approach. Roughly half of people with MS experience chronic pain, and it can range from burning nerve pain in the hands and feet to painful muscle spasms, facial nerve attacks, and secondary back or joint pain. The medication that works best for you depends entirely on which type of pain you’re dealing with.
Why MS Pain Needs Different Medications
MS pain falls into three broad categories: neuropathic pain caused by damaged nerve pathways, spasticity-related pain from abnormal muscle activity, and musculoskeletal pain from posture changes or reduced mobility. A mechanism-based classification identifies at least nine distinct pain types in MS, including trigeminal neuralgia, ongoing burning in the extremities, painful tonic spasms, spasticity pain, optic neuritis pain, back pain, and headaches. Each one has a different underlying cause, which is why a medication that helps with nerve pain in your feet may do nothing for painful leg spasms.
Most medications used for MS pain are prescribed off-label. Very few are specifically approved by the FDA for MS-related pain, but doctors routinely use them based on strong evidence from neuropathic pain and spasticity research more broadly.
Nerve Pain: Gabapentin and Pregabalin
The most common MS pain is ongoing burning, tingling, or stabbing sensations in the arms and legs, affecting roughly 12 to 28 percent of people with MS. This is neuropathic pain, caused by lesions along the nerve pathways that carry pain signals to the brain. First-line treatment relies on anticonvulsants that calm overactive nerve signaling, specifically gabapentin and pregabalin.
Pregabalin binds more tightly to its target in the nervous system than gabapentin does, giving it stronger pain-relieving effects at lower doses. For this reason, doctors sometimes switch patients from gabapentin to pregabalin if the first drug isn’t providing enough relief. Gabapentin also has a quirk in how it’s absorbed: the body can only take in so much at a time because it relies on a single transport system in the gut, which can become saturated. This means that simply increasing the dose doesn’t always produce proportionally better results.
The most common side effects of both drugs are dizziness and drowsiness, occurring in more than 20 percent of patients. Confusion and swelling in the hands or feet can also occur. These side effects are dose-dependent and reversible, meaning they get worse at higher doses and go away when the medication is reduced or stopped.
Antidepressants for Nerve Pain
Tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors (SNRIs) like duloxetine are also considered first-line options for neuropathic pain. They work by boosting the activity of chemical messengers in the spinal cord that naturally dampen pain signals. These can be particularly useful if you also experience depression or sleep problems alongside your pain, since they address multiple symptoms at once. Tricyclics tend to cause more drowsiness and dry mouth, while SNRIs are generally better tolerated.
Trigeminal Neuralgia: Carbamazepine and Oxcarbazepine
About 2 to 5 percent of people with MS develop trigeminal neuralgia, an intense, electric shock-like pain in the face. It’s one of the most severe pain conditions in medicine and requires its own treatment approach. The first-line medications are carbamazepine and oxcarbazepine, both sodium-channel blockers that quiet the abnormal nerve firing responsible for the attacks.
The challenge with these drugs in MS is tolerability. Their sedative effects and impact on coordination can worsen existing MS symptoms like fatigue and balance problems, which often leads doctors to consider surgical options earlier than they would for someone without MS. Surgical procedures range from minimally invasive nerve-targeting techniques to a more involved approach that relieves pressure on the trigeminal nerve.
Spasticity Pain: Baclofen and Tizanidine
Spasticity, the stiffness and involuntary muscle tightening caused by damage to motor pathways, affects up to half of people with MS and is a major source of pain. The muscles are essentially stuck in an overactive state, leading to constant tension, cramping, and painful spasms. Painful tonic spasms, a related but distinct problem involving sudden intense muscle contractions, affect 6 to 11 percent of MS patients.
Baclofen is the most widely used first-line treatment for spasticity. It works by mimicking a calming brain chemical at receptors in the spinal cord, reducing the signals that keep muscles contracted. For people whose spasticity doesn’t respond well enough to pills, or who can’t tolerate the drowsiness that comes with higher oral doses, an intrathecal baclofen pump can deliver the drug directly into the fluid surrounding the spinal cord. This approach is especially effective for lower-limb spasticity because the drug concentration is highest at lower spinal levels.
Tizanidine is another common option and is often used alongside baclofen for an additive effect. Gabapentin also pulls double duty here: if you have both nerve pain and spasticity, it can address both, which simplifies your medication regimen. For spasticity that’s concentrated in specific muscle groups, botulinum toxin injections target those muscles directly without the generalized drowsiness and weakness that come with oral medications.
Cannabinoid-Based Treatment
Nabiximols, a mouth spray containing equal parts THC and CBD derived from the cannabis plant, has emerged as an add-on treatment for MS patients whose spasticity doesn’t respond adequately to standard medications. Clinical data shows it significantly reduces both subjective spasticity scores and objective measures of muscle tightness. Beyond spasticity, studies have found it also reduces pain scores, the number of daily muscle spasms, and even bladder urgency.
The spray works by activating cannabinoid receptors in the brain and spinal cord, which helps rebalance the excitatory and inhibitory signals that control muscle tone. Research using neurophysiological measurements has confirmed that nabiximols increases inhibitory activity in the brain’s motor cortex and reduces excitability at the spinal level. Availability varies by country. It is approved in several European and other nations for MS spasticity but is not widely available in the United States.
Topical Options for Localized Pain
When nerve pain is concentrated in a specific area, topical lidocaine patches offer a way to get relief without the systemic side effects of oral medications. Each patch contains 5 percent lidocaine and is applied for up to 12 hours, followed by at least 12 hours without a patch. Up to three patches can be used at once, and they can be cut to fit the painful area. In clinical comparisons, about 28 percent of patients using lidocaine patches achieved at least a 30 percent reduction in pain, compared with roughly 5 percent on placebo patches. The evidence quality is limited, but the low risk of side effects makes them a reasonable option to try, especially as part of a broader pain management plan.
Why Opioids Are Not Recommended
Opioids are not considered appropriate for ongoing MS pain management. CDC guidelines are clear that nonopioid therapies are preferred for subacute and chronic pain, and opioids should not be used as first-line or routine treatment. Clinical evidence has found insufficient proof that opioids provide long-term benefits for chronic pain, while the risks are well established: increased rates of opioid use disorder, overdose, falls, fractures, and death, all in a dose-dependent pattern. For someone with MS who may already have balance and mobility challenges, the added fall risk is particularly concerning.
Lhermitte’s Sign and Other Transient Pains
About 15 percent of people with MS experience Lhermitte’s phenomenon, an electric shock-like sensation that runs down the spine or into the limbs when you bend your neck forward. It’s caused by demyelination in the spinal cord’s sensory pathways. This symptom is often brief and intermittent enough that it doesn’t require dedicated medication, but when it’s frequent or severe, the same anticonvulsants used for other neuropathic pain (gabapentin, pregabalin, or carbamazepine) can help.
Optic neuritis, which causes eye pain in about 8 percent of MS patients, is typically managed as part of an MS relapse rather than with long-term pain medications. The pain comes from inflammation within the optic nerve itself and generally resolves as the inflammation is treated.
Matching Your Pain to the Right Medication
The practical takeaway is that effective MS pain treatment starts with identifying what kind of pain you have. Burning or tingling in the extremities points toward gabapentin, pregabalin, or an antidepressant. Facial shock-like pain calls for carbamazepine or oxcarbazepine. Stiffness, cramping, and spasms respond to baclofen, tizanidine, or botulinum toxin injections. Many people with MS experience more than one pain type simultaneously, which often means combining medications from different categories.
Because so much of MS pain treatment is off-label and involves trial and adjustment, finding the right combination typically takes time. What works well for one person may not work for another, even with the same type of pain, because the location and extent of nerve damage varies from person to person. Starting at low doses and increasing gradually helps minimize side effects while finding the dose that provides meaningful relief.